282 related articles for article (PubMed ID: 25104873)
1. The clinicopathological significance of miR-133a in colorectal cancer.
Wan TM; Lam CS; Ng L; Chow AK; Wong SK; Li HS; Man JH; Lo OS; Foo D; Cheung A; Yau T; Poon JT; Poon RT; Law WL; Pang RW
Dis Markers; 2014; 2014():919283. PubMed ID: 25104873
[TBL] [Abstract][Full Text] [Related]
2. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
3. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer.
Chen WS; Leung CM; Pan HW; Hu LY; Li SC; Ho MR; Tsai KW
Oncol Rep; 2012 Sep; 28(3):1069-76. PubMed ID: 22766685
[TBL] [Abstract][Full Text] [Related]
4. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
Sui Y; Zhang X; Yang H; Wei W; Wang M
Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
[TBL] [Abstract][Full Text] [Related]
6. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
7. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
10. MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
Shen Y; Yang Y; Li Y
Thorac Cancer; 2020 Dec; 11(12):3473-3481. PubMed ID: 33074595
[TBL] [Abstract][Full Text] [Related]
11. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
12. LINC01123 Promotes the Progression of Colorectal Cancer via miR-625-5p/LASP1 Axis.
Shang T; Zhou X; Chen W
Cancer Biother Radiopharm; 2021 Nov; 36(9):765-773. PubMed ID: 32423238
[No Abstract] [Full Text] [Related]
13. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
Wang W; Ji G; Xiao X; Chen X; Qin WW; Yang F; Li YF; Fan LN; Xi WJ; Huo Y; Wen WH; Yang AG; Wang T
Oncotarget; 2016 Oct; 7(42):68674-68687. PubMed ID: 27626692
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
Zhou T; Zhang G; Liu Z; Xia S; Tian H
Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
[TBL] [Abstract][Full Text] [Related]
15. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
[TBL] [Abstract][Full Text] [Related]
16. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
Qin Y; Dang X; Li W; Ma Q
Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
[TBL] [Abstract][Full Text] [Related]
18. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract][Full Text] [Related]
19. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
